BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26017793)

  • 1. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.
    Jin Y; Yuan MQ; Chen JQ; Zhang YP
    Clinics (Sao Paulo); 2015 Apr; 70(4):264-72. PubMed ID: 26017793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
    Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
    Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
    Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
    Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
    BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
    Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
    Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
    Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
    Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
    Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
    Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pretreatment serum alkaline phosphatase in nasopharyngeal carcinoma.
    Xie Y; Wei ZB; Duan XW
    Asian Pac J Cancer Prev; 2014; 15(8):3547-53. PubMed ID: 24870755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.
    Li G; Gao J; Tao YL; Xu BQ; Tu ZW; Liu ZG; Zeng MS; Xia YF
    Chin J Cancer; 2012 Apr; 31(4):197-206. PubMed ID: 22237040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients.
    Yuan J; Xu M; Li J; Li N; Chen LZ; Feng QS; Zeng YX
    Clinics (Sao Paulo); 2016 Jul; 71(6):338-43. PubMed ID: 27438568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
    Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
    Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
    Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
    Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
    Cao X; Han Y; He L; Xiang J; Wen Z
    Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
    Lan M; Chen C; Huang Y; Mao M; Han F; Liao J; Deng M; Duan Z; Zheng L; Wu S; Lu T; Jian Y
    Oncotarget; 2016 Jul; 7(29):46242-46252. PubMed ID: 27323828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
    Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
    Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
    Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
    Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
    Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
    Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
    PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.